Affinity DataIC50: 7nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 60nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 60nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 60nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 60nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 70nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 70nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 70nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 90nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 130nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 150nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 150nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 190nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 300nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Affinity DataIC50: 300nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair